RE: Share price movement16 Nov 2023 14:13
Yep, there are just over 121m shares in issue but, importantly, only 68% are in public hands with the balance owned by Directors (c18%) and long term (pre listing) investors.
So we have a low free float, huge Director alignment, long term backing, and are at the forefront of a growing market with massive potential. Any good commercial news here will, in my view, see the price rise significantly.
Short term prospects for that seem to me to be another Salistick retailer (I reckon Asda!), Salistick FDA approval, Loop trial results and UKCA approval, and Upfront Dx trial results, all of which could come by the end of this year.